Suppression of the HIV-1 reservoir with a potent Tat inhibitor

Suppression of the HIV-1 reservoir with a potent Tat inhibitor

Bibliographic Details
Main Authors:	S. Valente, C.F. Kessing, G. Mousseau, S. Mediouni, R. Fromentin, N. Chomont, L. Trautmann
Format:	Article
Language:	English
Published:	Elsevier 2015-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020314060

Similar Items

Potent suppression of HIV viral replication by a novel inhibitor of Tat
by: Mousseau Guillaume, et al.
Published: (2012-05-01)

Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription
by: Guillaume Mousseau, et al.
Published: (2019-07-01)

Resistance to the Tat inhibitor didehydro-cortistatin A is mediated by heightened basal HIV-1 transcription
by: S. Mediouni, et al.
Published: (2019-12-01)

Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors
by: Susana Valente, et al.
Published: (2012-11-01)

Molecular characterisation of the inhibitor didehydro-Cortistatin A with the HIV-1 Tat protein
by: S. Mediouni, et al.
Published: (2017-12-01)

Potent suppression of HIV-1 cell attachment by Kudzu root extract
by: S. Mediouni, et al.
Published: (2018-09-01)

Potent inhibition of HIV-1 replication by a Tat mutant.
by: Luke W Meredith, et al.
Published: (2009-11-01)

Tat inhibition by didehydro-cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
by: C. Li, et al.
Published: (2019-12-01)

The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders
by: Susana T Valente, et al.
Published: (2015-10-01)

Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
by: Chuan Li, et al.
Published: (2019-04-01)

In vivo suppression of HIV rebound by didehydro-Cortistatin A, a ‘block-and-lock’ strategy for HIV-1 cure
by: C.F. Kessing, et al.
Published: (2017-12-01)

In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment
by: Cari F. Kessing, et al.
Published: (2017-10-01)

Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV rev trafficking.
by: Min-Hsuan Lin, et al.
Published: (2012-01-01)

Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat
by: Sonia Mediouni, et al.
Published: (2019-02-01)

HIV-1 Tat and T cell apoptosis
by: Krammer Peter H
Published: (2006-12-01)

Mechanism of HIV-1 Tat RNA translation and its activation by the Tat protein
by: López-Lastra Marcelo, et al.
Published: (2009-08-01)

Proteomic characterization of HIV-1 Tat interactome
by: Hall WW, et al.
Published: (2006-12-01)

Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A
by: Andrew P. Rice
Published: (2019-07-01)

Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways
by: Dionisio A. Olmedo, et al.
Published: (2017-02-01)

Rational Design, Synthesis, and Evaluation of Inhibitors for the HIV-1 TAT Interacting Protein Tip60
by: Ngo, Liza D
Published: (2013)

HIV-1 Tat: Role in Bystander Toxicity
by: David Ajasin, et al.
Published: (2020-02-01)

Immunomodulatory properties of the HIV-1 Tat protein
by: Nicoli, Francesco
Published: (2013)

In vivo massive expansion of a T-cell clone carrying a defective HIV genome: implication for the measurement of the HIV reservoir
by: R. Fromentin, et al.
Published: (2017-12-01)

HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia
by: Giovanni Sarnelli, et al.
Published: (2018-03-01)

HIV-1 Tat interacts with LIS1 protein
by: Turner Willie, et al.
Published: (2005-02-01)

Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat
by: Muller Sylviane, et al.
Published: (2008-07-01)

Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription
by: Gordeuk Victor R, et al.
Published: (2006-11-01)

HIV, Tat and dopamine transmission
by: Peter J. Gaskill, et al.
Published: (2017-09-01)

Large in vivo expansion and subsequent partial contraction of a T cell clone carrying a defective HIV genome reflect the dynamics of the HIV reservoir during ART
by: R. Fromentin, et al.
Published: (2019-07-01)

Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine
by: Annappa Sylvie, et al.
Published: (2006-01-01)

HIV-1 Tat Length: Comparative and Functional Considerations
by: Anthony R. Mele, et al.
Published: (2020-03-01)

<it>In vitro </it>nuclear interactome of the HIV-1 Tat protein
by: Hall William W, et al.
Published: (2009-09-01)

HIV-1 Tat alters neuronal intrinsic excitability
by: Walter Francesconi, et al.
Published: (2018-05-01)

Role of Endolysosomes in HIV-1 Tat-Induced Neurotoxicity
by: Liang Hui, et al.
Published: (2012-05-01)

Structure-function relationships of the HIV-1 Tat protein
by: Loret Erwann P
Published: (2009-09-01)

Recruitment and activation of RSK2 by HIV-1 Tat.
by: Claudia Hetzer, et al.
Published: (2007-01-01)

HIV-1 Tat interaction with Dicer: requirement for RNA
by: Jeang Kuan-Teh, et al.
Published: (2006-12-01)

<it>In vitro </it>nuclear interactome of the HIV-1 Tat protein
by: Gautier Virginie W, et al.
Published: (2009-05-01)

HIV-1 Tat protein enhances Microtubule polymerization
by: Prevot Charles, et al.
Published: (2005-02-01)

Structural and functional characterisation of the HIV 1 Tat protein
by: Olek, Sven Stefan
Published: (2001)

Cannot write session to /tmp/vufind_sessions/sess_t73tgnl6um0fp8efekocc8q36g